Manpreet Chadha

First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas

Amita Patnaik, Leonard J. Appleman, Anthony W. Tolcher et al. · Annals of Oncology · 2016 · 229 citations · Full text

A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer

Gayle Jameson, Emanuel F. Petricoin, Jasgit C. Sachdev et al. · Breast Cancer Research and Treatment · 2014 · 82 citations

Systems Biology, Metastatic Breast Cancer, Breast Oncology +11

First-in-human trial of novel oral PARP inhibitor BMN 673 in patients with solid tumors.

Johann S. de Bono, Lida A. Mina, Michael Gonzalez et al. · Journal of Clinical Oncology · 2013 · 75 citations

Solid Tumors, Immunology, Parp Activity +17

Effect of 25‐hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients

Manpreet Chadha, Marwan Fakih, Josephia R. Muindi et al. · The Prostate · 2010 · 53 citations · Full text

Vitamin D deficiency and insufficiency among patients with prostate cancer

Donald L. Trump, Manpreet Chadha, Annette Y. Sunga et al. · British Journal of Urology · 2009 · 51 citations · Full text